it s safer than the other vaccine. the old generation smallpox vaccine, we have 100 million doses already in our stockpile for that but we re reluctant to use it because it has reactions, and it replicates very well in damaged skin from people who have eczema or immuno compromise and the safety spectrum in much less for the older generation vaccine. who should be getting the vaccine today? right now i think of it as a form of post-exposure prophylaxis and pre-exposure prophylaxis. so certainly anyone who is engaged in the high-risk communities urgently need that. we need to accelerate as many doses as possible. but don t be sfrurprised if the numbers continue to decline that this will become more generalized in the u.s. population and we ll have to expand the numbers of those who
NASDAQ: CureVac Aktie nachbörslich MINUS 50 % „Und Sie sind raus – Nur 47 % Wirksamkeit zerstört Träume
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
CureVac: Starke Daten zu Corona-Impfstoff der zweiten Generation - Aktienanalyse (Der Aktionär) | Aktien des Tages
aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.